Reveal LINQ

Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System

ANZCTR Trial ID: NCT01965899

The purpose of the Reveal LINQ Usability Study is to assess the functionality of the Reveal LINQ insertable cardiac monitor and accompanying system in patients indicated for an insertable cardiac monitor.

Please contact Jonathon Foote for more information.


  • Professor Sanders says...

    Atrial fibrillation is a consequence of several reversible risk factors - high blood pressure, diabetes, obesity, sleep apnoea, and excessive alcohol. Your management of atrial fibrillation must include strict control of these risk factors.